Search results for "Betics"

showing 10 items of 15 documents

Analysis of T-Lymphocyte Subsets After Phytohemagglutinin Stimulation in Normal and Type 1 Diabetic Mothers and Their Infants

1992

Our aim was to investigate the immunological status of diabetic pregnancy, which is an overlap of diabetic immunity abnormalities and the immunological modifications normally occurring during pregnancy. METHOD: We studied lymphocyte subpopulations and lymphokine production, after 96 h of phytohemagglutinin (PHA) stimulation, from normal and Type I diabetic pregnant women at delivery time and from the respective cord blood. RESULTS: Peripheral blood mononuclear cells (PBMC) from both normal and Type I diabetic mothers showed an increase in CD8+ and a decrease in CD4+ cells compared to the respective cord blood mononuclear cells (CBMC). Moreover, Type I PBMC showed a lower number of “activate…

Adultmedicine.medical_specialtyCellular immunityCD3ImmunologyPregnancy in DiabeticsLymphocyte ActivationPeripheral blood mononuclear cellInterferon-gammaAntigens CDPregnancyT-Lymphocyte SubsetsInternal medicinemedicineHumansImmunology and AllergyIL-2 receptorPhytohemagglutininsCells CulturedImmunity CellularbiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryLymphokineObstetrics and GynecologyReceptors Interleukin-2HLA-DR AntigensT lymphocyteFetal BloodFlow CytometryDiabetes Mellitus Type 1EndocrinologyReproductive MedicineCord bloodImmunologybiology.proteinInterleukin-2FemalebusinessCD8Interleukin-1American Journal of Reproductive Immunology
researchProduct

N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring.

2006

We investigated the role of dietary n-3 polyunsaturated fatty acids (n-3 PUFA) in the modulation of total antioxidant status in streptozotocin (STZ)-induced diabetic rats and their macrosomic offspring. Female wistar rats, fed on control diet or n-3 PUFA diet, were rendered diabetic by administration of five mild doses of STZ on day 5 and were killed on days 12 and 21 of gestation. The macrosomic (MAC) pups were killed at the age of 60 and 90 days. Lipid peroxidation was measured as the concentrations of plasma thiobarbituric acid reactive substances (TBARS), and the total antioxidant status was determined by measuring (i) plasma oxygen radical absorbance capacity (ORAC), (ii) plasma vitami…

Vitaminmedicine.medical_specialtyAntioxidantErythrocytesOxygen radical absorbance capacityEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPregnancy in DiabeticsMedicine (miscellaneous)Ascorbic AcidThiobarbituric Acid Reactive SubstancesAntioxidantsDiabetes Mellitus ExperimentalFetal MacrosomiaLipid peroxidationchemistry.chemical_compoundPregnancyInternal medicineFatty Acids Omega-3TBARSmedicineDiabetes MellitusAnimalsVitamin ERats WistarVitamin Achemistry.chemical_classificationGlutathione PeroxidaseNutrition and DieteticsVitamin CTriglycerideChemistrySuperoxide DismutaseFatty AcidsFree Radical ScavengersLipidsRatsEndocrinologyAnimals NewbornDiabetes Mellitus Type 2FemaleLipid PeroxidationBiomarkersPolyunsaturated fatty acidInternational journal of obesity (2005)
researchProduct

Spectrum of congenital anomalies in pregnancies with pregestational diabetes

2012

BACKGROUND Maternal pregestational diabetes is a well-known risk factor for congenital anomalies. This study analyses the spectrum of congenital anomalies associated with maternal diabetes using data from a large European database for the population-based surveillance of congenital anomalies. METHODS: Data from 18 population-based EUROCAT registries of congenital anomalies in 1990-2005. All malformed cases occurring to mothers with pregestational diabetes (diabetes cases) were compared to all malformed cases in the same registry areas to mothers without diabetes (non-diabetes cases). RESULTS: There were 669 diabetes cases and 92,976 non diabetes cases. Odds ratios in diabetes pregnancies re…

MaleEmbryologyPediatricsPregestational DiabetesPregnancy in DiabeticsMELLITUSPregnancyRisk FactorsNeural Tube DefectsRegistriesLivebirthsRISKeducation.field_of_studyOUTCOMESlivebirthsWOMENEarGeneral MedicineASSOCIATIONCongenital AnomaliesEuropeAnotiaPopulation SurveillanceFemaleNEURAL-TUBE DEFECTSLive BirthHernia UmbilicalAdultHeart Defects Congenitalmedicine.medical_specialtyPopulationPopulation Basedpopulation basedCongenital AbnormalitiesYoung AdultDiabetes mellitusAnencephalyBIRTH-DEFECTSmedicineDiabetes MellitusHumansMALFORMATIONSRisk factoreducationTYPE-1Congenital MicrotiaOmphaloceleSpina bifidabusiness.industrycongenital anomaliesInfant NewbornOdds ratioNATIONWIDEmedicine.diseaseEstados de Saúde e de Doençapregestational diabetesPregnancy ComplicationsPediatrics Perinatology and Child HealthbusinessDevelopmental BiologyBirth Defects Research. Part A: Clinical and Molecular Teratology
researchProduct

Advances in pharmacological treatment of type 1 diabetes during pregnancy.

2019

Introduction: In women with type 1 diabetes mellitus (T1DM), pregnancy is associated with a potential risk of maternal, foetal and neonatal outcomes. Stringent metabolic control is required to improve these outcomes. Areas covered: In this review, the authors summarise the current evidence from studies on the pharmacological therapy and on monitoring of T1DM during pregnancy. The authors also discuss the use of new technologies to improve therapeutic management and patient compliance. Expert opinion: Pre-conception counselling is essential in T1DM to minimise pregnancy risks. Pregnancy in T1DM is always considered a high-risk pregnancy. During pregnancy, the target haemoglobin A1C (HbA1c) i…

Blood Glucoseendocrine system diseasesPregnancy in DiabeticsDiabetic complicationBioinformaticsPharmacological treatmenttype 1 diabetes mellitu03 medical and health sciences0302 clinical medicinePregnancymedicineHumansHypoglycemic AgentsInsulinPharmacology (medical)PharmacologyType 1 diabetesPregnancyPotential riskbusiness.industryCesarean Sectionnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseHypoglycemiaglycaemic controlDiabetes Mellitus Type 1Neonatal outcomes030220 oncology & carcinogenesisMetabolic control analysisFemalebusiness030217 neurology & neurosurgeryExpert opinion on pharmacotherapy
researchProduct

Implication of lipids in macrosomia of diabetic pregnancy: can n-3 polyunsaturated fatty acids exert beneficial effects?

2003

Macrosomia or fetal obesity is a frequent complication of pregnancy in diabetes mellitus. Several alterations observed in carbohydrate and lipid metabolism in macrosomic infants of diabetic mothers are thought to be a consequence of maternal hyperglycaemia leading to fetal hyperinsulinaemia. Macrosomic infants of diabetic mothers are prone to the development of glucose intolerance, obesity and diabetes during childhood and adulthood. Furthermore, increasing evidence is accumulating regarding the importance of n-3 polyunsaturated fatty acids (PUFAs) in the reduction of plasma lipids and hyperglycaemia. In this review article, we shed light on the abnormalities in lipid metabolism in macrosom…

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesLipoproteinsPregnancy in DiabeticsFetal MacrosomiaPregnancyDiabetes mellitusInternal medicineFatty Acids Omega-3Diabetes MellitusmedicineAnimalsHumansObesitychemistry.chemical_classificationPregnancyFetusbusiness.industryMetabolic disorderInfant NewbornLipid metabolismGeneral MedicineLipid Metabolismmedicine.diseaseObesityGestational diabetesEndocrinologychemistryFemaleInsulin ResistancebusinessPolyunsaturated fatty acidClinical Science
researchProduct

Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds

2021

AbstractThe five-membered pyrrolidine ring is one of the nitrogen heterocycles used widely by medicinal chemists to obtain compounds for the treatment of human diseases. The great interest in this saturated scaffold is enhanced by (1) the possibility to efficiently explore the pharmacophore space due to sp3-hybridization, (2) the contribution to the stereochemistry of the molecule, (3) and the increased three-dimensional (3D) coverage due to the non-planarity of the ring—a phenomenon called “pseudorotation”. In this review, we report bioactive molecules with target selectivity characterized by the pyrrolidine ring and its derivatives, including pyrrolizines, pyrrolidine-2-one, pyrrolidine-2…

Steric effectsPyrrolidinesMolecular StructureChemistryDrug discoveryEnantioselective synthesisStereoisomerismGeneral ChemistryReviewAnti-inflammatory and analgesic agentsRing (chemistry)Combinatorial chemistrySettore CHIM/08 - Chimica FarmaceuticaPyrrolidineProlinolPyrrolidinechemistry.chemical_compoundAntidiabeticsDrug DiscoveryPseudorotationHumansAnticancer and antibacterial agentsPharmacophoreCentral nervous system diseases
researchProduct

Evaluation of B-cell secretion and peripheral insulin resistance during pregnancy and after delivery in gestational diabetes mellitus with obesity

1988

Nine pregnant women with gestational diabetes mellitus (GDM) were studied. Six normal pregnant women and six normal nonpregnant women were evaluated as control groups. All the women underwent oral glucose tolerance test and glucose clamp during the third trimester of pregnancy and two months after delivery. During OGTT, glucose, C-peptide and insulin plasma levels were determined. C-peptide and insulin values in the late phase of OGTT were higher during pregnancy than after delivery in both groups. In gestational diabetic women, the M-value in the second steady-state during glucose clamp was lower than in controls, both during pregnancy and after delivery. Nevertheless, in both groups the M…

Blood GlucoseAdultmedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPregnancy in DiabeticsObesity; Glucose Tolerance Test; Reference Values; Humans; Diabetes Mellitus; Islets of Langerhans; Insulin; Blood Glucose; Pregnancy; Puerperal Disorders; Adult; Insulin Resistance; Female; Pregnancy in DiabeticsIslets of LangerhansEndocrinologyInsulin resistanceReference ValuesPregnancyDiabetes mellitusInternal medicineInternal MedicinemedicineDiabetes MellitusHumansInsulinObesityPregnancyGlucose tolerance testSettore MED/12 - Gastroenterologiamedicine.diagnostic_testbusiness.industryInsulinGeneral MedicinePuerperal DisordersGlucose clamp techniqueGlucose Tolerance Testmedicine.diseaseGestational diabetesEndocrinologyGestationFemaleInsulin Resistancebusiness
researchProduct

Effects of Vildagliptin/Metformin Therapy on Patient-Reported Outcomes: Work Productivity, Patient Satisfaction, and Resource Utilization

2013

Introduction: Type 2 diabetes mellitus (T2DM) is associated not only with high direct healthcare costs, but also with indirect costs, as diabetic complications and the disease itself result in loss of productivity. Vildagliptin is a novel dipeptidyl peptidase-4 inhibitor that is given either alone or in combination with oral hypoglycemic drugs, including metformin. The study was designed to assess the hypothesis that fixed-combination vildagliptin/metformin improves work productivity measured as Work Productivity and Activity Impairment (WPAI) scores. Secondary objectives were the assessment of patient satisfaction by means of the Diabetes Treatment Satisfaction Questionnaire (DTSQs), the c…

MalePyrrolidinesSettore MED/09 - Medicina Internaendocrine system diseasesAdamantaneEfficiencyoutcomeschemistry.chemical_compoundIndirect costsDiabetes mellitusVildagliptinPharmacology (medical)Prospective StudiesPatient-reported outcomeProductivityAged 80 and overVildagliptinMedicine(all)Health Care CostsGeneral MedicineHealth ServicesMiddle AgedMetforminMetforminType 2 diabetes mellituDrug CombinationsTreatment OutcomeItalyPatient SatisfactionFemalemedicine.drugAdultEmploymentResourcemedicine.medical_specialtyDiabetes mellitus; oral antidiabetics; vildagliptin; outcomesoral antidiabeticsPatient satisfactionInternal medicineDiabetes mellitusNitrilesmedicineHumansHypoglycemic AgentsHealthcare costFixed combinationAgedbusiness.industryType 2 Diabetes Mellitusnutritional and metabolic diseasesmedicine.diseaseEndocrinologyDiabetes Mellitus Type 2chemistryEmergency medicineObservational studyGlycated hemoglobinbusinessAdvances in Therapy
researchProduct

In vitro effects of vitamins C and E, n-3 and n-6 PUFA and n-9 MUFA on placental cell function and redox status in type 1 diabetic pregnant women.

2016

IF 2.972; International audience; The aim of this investigation was to determine the in vitro effects of vitamin C and E, n-3 and n-6 PUFA and n-9 MUFA on placental cell proliferation and function in type 1 diabetes. Placenta tissues were collected from 30 control healthy and 30 type 1 diabetic women at delivery. Placental cells were isolated and were cultured in RPMI medium supplemented with vitamin C (50 μM), vitamin E (50 μM), n-3 PUFA (100 μM), n-6 PUFA (100 μM) or n-9 MUFA (100 μM). Cell proliferation, cell glucose uptake and intracellular oxidative status were investigated. Our results showed that basal placental cell proliferation, glucose uptake, malondialdehyde (MDA) and carbonyl p…

0301 basic medicineAntioxidantGlucose uptakemedicine.medical_treatmentPlacentaProliferationPregnancy in DiabeticsAscorbic Acidmedicine.disease_causeAntioxidantsFatty Acids Monounsaturatedchemistry.chemical_compound0302 clinical medicinePregnancyMalondialdehydeVitamin EVitamin C[ SDV.MHEP.GEO ] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics030219 obstetrics & reproductive medicineTrophoblastObstetrics and Gynecologyfood and beveragesCatalasemedicine.anatomical_structureType 1 diabetes[ SDV.BDLR ] Life Sciences [q-bio]/Reproductive BiologyHypertensionFemalelipids (amino acids peptides and proteins)Oxidant/antioxidant statusOxidation-ReductionIntracellularPolyunsaturated fatty-acidsVitaminAdultRiskmedicine.medical_specialtyPlacental cellsBiology03 medical and health sciencesYoung AdultInternal medicinePlacentaFatty Acids Omega-6Fatty Acids Omega-3medicineHumans[ SDV.BDD ] Life Sciences [q-bio]/Development BiologyCell ProliferationVitamin CSuperoxide DismutaseVitamin EMellitusPreeclampsiaDiet030104 developmental biologyEndocrinologyDiabetes Mellitus Type 1MetabolismReproductive MedicinechemistryOxidative stressOxidative stressPUFADevelopmental Biology
researchProduct

n-3 Fatty Acids Modulate T-Cell Calcium Signaling in Obese Macrosomic Rats

2004

Objective: We investigated the effects of a diet containing EPAX-7010, rich in PUFAs such as eicosapentaenoic acid [20:5(n-3)] and docosahexaenoic acid [22:6(n-3)], i.e., a PUFA/EPAX regimen, on T-cell activation in diabetic pregnant rats and their obese pups. Research Methods and Procedures: Mild hyperglycemia in pregnant rats was induced by intraperitoneal injection of streptozotocin on Day 5 of gestation. T-cell blastogenesis was assayed by using 3H-thymidine, whereas intracellular free calcium concentrations ([Ca2+]i) were measured by using Fura-2 in diabetic pregnant rats and their obese offspring. Results: Concavalin-A-stimulated T-cell proliferation was decreased in both pregnant dia…

medicine.medical_specialtyOffspringT-LymphocytesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentIntraperitoneal injectionPregnancy in DiabeticsMedicine (miscellaneous)Gestational AgeLymphocyte ActivationDiabetes Mellitus ExperimentalFetal MacrosomiaEndocrinologyDietary Fats UnsaturatedPregnancyDiabetes mellitusInternal medicineFatty Acids Omega-3Concanavalin AmedicineAnimalsObesityRats Wistarchemistry.chemical_classificationCalcium metabolismbusiness.industryIonomycinPublic Health Environmental and Occupational Healthmedicine.diseaseStreptozotocinEicosapentaenoic acidRatsEndocrinologychemistryDocosahexaenoic acidThapsigarginCalciumFemalebusinessSpleenSignal TransductionFood SciencePolyunsaturated fatty acidmedicine.drugObesity Research
researchProduct